Weekly Docetaxel and Bortezomib as First-Line Treatment for Patients with Hormone-Refractory Prostate Cancer: A Minnie Pearl Cancer Research Network Phase II Trial
John D. Hainsworth, Anthony A. Meluch, David R. Spigel, John Barton Jr, Lisa Simons, Christina Meng, Bruce Gould, F. Anthony GrecoVolume:
5
Year:
2007
Language:
english
Pages:
6
DOI:
10.3816/cgc.2007.n.004
File:
PDF, 147 KB
english, 2007